Cellular Invasion Mechanisms in Cancer and Pregnancy

Cellular invasion underlies both the physiological process of placentation in pregnancy and the pathological progression of cancer metastasis. In the context of pregnancy, specialised trophoblast cells breach the maternal endometrium and remodel uterine spiral arteries to establish an adequate blood supply to the developing foetus. This invasion is tightly regulated by a balance of pro-invasive signals—such as matrix metalloproteinases and epithelial–mesenchymal transition programmes—and inhibitory feedback from decidual stromal cells and immune regulators to prevent excessive tissue damage. In cancer, by contrast, malignant cells co-opt many of the same molecular pathways—upregulation of metalloproteinases, integrin-mediated adhesion changes, angiogenic factor secretion and immune-checkpoint exploitation—to escape the primary tumour, traverse basement membranes, enter the vasculature and colonise distant sites. Although both processes deploy similar effectors, trophoblast invasion is spatially and temporally confined, whereas tumour invasion is uncontrolled and progressive. Comparative research has revealed key shared drivers—growth factors, extracellular matrix remodelling enzymes, angiogenic cytokines and immune-modulatory molecules—and also highlighted crucial differences in feedback regulation and cell-intrinsic checks on invasiveness. Understanding these convergent and divergent mechanisms offers avenues for novel anti-metastatic therapies and improved management of pregnancy disorders arising from aberrant trophoblast behaviour.

Research from Nature Portfolio

Recent studies have dissected the impact of naturally occurring genetic variation on tissue invasibility. A high-frequency allele that elevates endometrial Wnt4 expression was shown to enhance permissiveness for embryo implantation by modulating stromal remodelling and downregulating epithelial proliferation. While this shift facilitates deeper trophoblast invasion under hormonal control, it concomitantly reduces resistance to invasion by malignant cells in other estrogen-responsive tissues. These findings illustrate how subtle alterations in a single transcriptional regulator can exert opposing effects on pregnancy success and cancer susceptibility, illuminating pleiotropic mechanisms that co-ordinate reproductive fitness and tumour progression.

Cellular Invasion Mechanisms in Cancer and Pregnancy publication trend

The graph below shows the total number of articles in cellular invasion mechanisms in cancer and pregnancy across all publications each year (not limited to Nature Index journals).

Technical terms

Trophoblast: A specialised foetal cell type that invades the maternal endometrium to form the placenta and establish nutrient and gas exchange.

Epithelial–Mesenchymal Transition (EMT): A cellular programme in which epithelial cells lose polarity and adhesion to acquire migratory and invasive properties.

Extracellular Matrix (ECM): A complex network of proteins and polysaccharides that provides structural support to tissues and whose controlled degradation enables cell invasion.

Angiogenesis: The formation of new blood vessels from pre-existing vasculature, critical for supplying oxygen and nutrients to invading cells in both placenta and tumours.

Immune Tolerance: A regulated state in which the immune system tolerates non-self antigens, crucial at the maternal–foetal interface to prevent rejection of the semi-allogeneic embryo.

References

1. A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis. Nature Communications (2024).
2. Investigation into the role of the MITA-TRIM38 interaction in regulating pyroptosis and maintaining immune tolerance at the maternal-fetal interface. Cell Death & Disease (2023).
3. Paracrine HB-EGF signaling reduce enhanced contractile and energetic state of activated decidual fibroblasts by rebalancing SRF-MRTF-TCF transcriptional axis. Frontiers in Cell and Developmental Biology (2022).
4. Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients. Journal of Clinical Medicine (2021).